D-Index & Metrics Best Publications

Christoph Rader

Scripps Research Institute
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Biology and Biochemistry D-index 60 Citations 10,682 216 World Ranking 8021 National Ranking 3641

Overview

What is he best known for?

The fields of study Christoph Rader is best known for:

Gene
Antibody
Immune system

His Drug course of study focuses on Pharmacology and Prodrug. His work on Immunology as part of general Multiple myeloma study is frequently linked to Cancer research, therefore connecting diverse disciplines of science. His Multiple myeloma research extends to Immunology, which is thematically connected. In his works, Christoph Rader conducts interdisciplinary research on Cancer research and Leukemia. While working in this field, Christoph Rader studies both Leukemia and Chronic lymphocytic leukemia. His research on Cell biology often connects related areas such as Cell adhesion molecule and Extracellular. In most of his Extracellular studies, his work intersects topics such as Cell biology. Christoph Rader is involved in relevant fields of research such as Catalysis and Polymer in the domain of Organic chemistry. He performs multidisciplinary study in the fields of Catalysis and Organic chemistry via his papers.

His most cited work include:

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity (719 citations)
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells (383 citations)
The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor (217 citations)

What are the main themes of his work throughout his whole career to date

Christoph Rader frequently studies issues relating to Chronic lymphocytic leukemia and Immunology. His Chronic lymphocytic leukemia study frequently draws connections to other fields, such as Immunology. He integrates Biochemistry with Cell biology in his study. Christoph Rader connects Cell biology with Biochemistry in his study. He connects Monoclonal antibody with Phage display in his research. He merges Phage display with Monoclonal antibody in his research. He connects Cancer research with Leukemia in his research. While working in this field, Christoph Rader studies both Leukemia and Cancer research. While working in this field, he studies both Molecular biology and Gene.

Christoph Rader most often published in these fields:

Immunology (61.60%)
Antibody (59.20%)
Biochemistry (57.60%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Lizhou Zhang;Cody B. Jackson;Huihui Mou;Amrita Ojha.
Nature Communications (2020)

624 Citations

Humanization of murine antibody

Barbas Carlos F;Rader Christoph.
(1998)

532 Citations

Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells

Michael Hudecek;Maria Teresa Lupo-Stanghellini;Paula L. Kosasih;Daniel Sommermeyer.
Clinical Cancer Research (2013)

489 Citations

The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity

Michael Hudecek;Michael Hudecek;Daniel Sommermeyer;Paula L. Kosasih;Anne Silva-Benedict;Anne Silva-Benedict.
Cancer immunology research (2015)

414 Citations

Phage display of combinatorial antibody libraries.

Christoph Rader;Carlos F Barbas.
Current Opinion in Biotechnology (1997)

341 Citations

A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries

Christoph Rader;David A. Cheresh;Carlos F. Barbas.
Proceedings of the National Academy of Sciences of the United States of America (1998)

331 Citations

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

Michael Hudecek;Michael Hudecek;Thomas M. Schmitt;Sivasubramanian Baskar;Maria Teresa Lupo-Stanghellini.
Blood (2010)

301 Citations

The Nogo-66 Receptor Homolog NgR2 Is a Sialic Acid-Dependent Receptor Selective for Myelin-Associated Glycoprotein

Karthik Venkatesh;Onanong Chivatakarn;Hakjoo Lee;Pushkar S. Joshi.
The Journal of Neuroscience (2005)

291 Citations

Methods for the generation of chicken monoclonal antibody fragments by phage display.

Jennifer Andris-Widhopf;Christoph Rader;Peter Steinberger;Roberta Fuller.
Journal of Immunological Methods (2000)

270 Citations

Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.

Sivasubramanian Baskar;Ka Yin Kwong;Thomas Hofer;Jessica M Levy.
Clinical Cancer Research (2008)

269 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Christoph Rader